granitryl2mg5tab NEW

Granitryl contains Granisetron, a potent and selective 5-HT3 receptor antagonist. It is primarily used to prevent nausea and vomiting associated with emetogenic cancer chemotherapy and radiotherapy. By blocking serotonin receptors in the gastrointestinal tract and the central nervous system, it effectively manages acute emetic episodes. This medication is typically administered under strict medical supervision to ensure optimal control of chemotherapy-induced nausea and vomiting, providing significant relief for patients undergoing intensive oncological treatments.